Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation

Clinical trial NCT06316960 · RECRUITING

Trial details

NCT number: NCT06316960
Sponsor: Children's Hospital of Soochow University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

AML, Childhood Relapse/Recurrence Refractory AML Core Binding Factor Acute Myeloid Leukemia C-KIT Mutation

Start date: 2024-03-01
Primary completion: 2026-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.